Post Reply
7681-7700 of 10899
TOMORROW
BIO CHEONG!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
ARR!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Hi,
I don't quite understand why share granting is good news? Share granting will dilute the share.
Anyone have a better explaination?
Thanks
TOMORROW!!!!!!!!!!!! BIOSENSORS!!!!!!!!!!!!! CHIONG!!!!!!!!!!!!!!!!!!!!! ARGGHHH!!!!!!!!!!!!!!!!!!!
XiaoMaGe San
Cannot agree more...
sound interesting......for the all the scenarios ..... ..... just waiting for the BIG squeeze ...
Novena San
A few scenarios i can think of
1.) As mention, shorties covered but yet to go long
2.) The shorts have yet to cover
3.) The shorts have yet to cover and if price continue to move up, there might be a short squeeze and u just might see a quick cheong up
Hey SM ..... does it means that the shortist have been converted to longist....
just checked today's CFD report from Phillips, BIG not on the list liao...
wait.. shortists dun run so fast, I just got my paycheck and fat bonus, looking for BIG bargain.
dun worry, even if takeover, at the most lose your pants only, still got tay kor. hee hee
this CFD shortists better close their posistion fast, when BIG cheong soon they will cry!
Hi Guys Was reading the Phillips CFD Morning Report for 27 Feb 2008, they indicated that BIG is NETT SHORT for Phillips CFD Below is extracted from the 27 Fed report. SMTop 10 SGX CFD Counters*
1. Synear Food (Net Short)
2. Celestial NutriFoods (Net Long)
3. Yangzijiang (Net Long)
4. Biosensors International Group
(Net Short)
5. Sino Techfibre (Net Short)
6. GoldenAgr (NEt Short)
7. Meiban (Neutral)
8. Lian Beng (Net Short)
9. JiutianC (Net Long)
10. Uni-Asia (Net Long)
*Net Long indicates that there are more buy
trades than sell trades done in the day for
CFD. Net Short indicates that there are
more sell trades than buy trades done in the
day for CFD.
 x 0
 x 0 |
Heard from a very reliable source that the stent used is from JNJ. |
It is very possible also. I have read some USA reports on people complaining about doctors anyhow use DES on patients. One guy wrote in and complain his father need a second implant after the first one re-clogged and his dad was using Cypher. But if use DES kena reclog, use BMS will be even worst. That is why if artey is very thin, risky to do stenting. Biomatrix has the lowest rate of late-loss (approx 0.11mm on average) which is within the optimal range of 0.1 to 0.2mm. A little late-loss is necessary and good. BMS normally has late-loss of 0.4 to 0.6mm. First generation DESs like Taxus and Cypher has been statistically shown to prevents approx 60 to 70% of repeat coronary revascularisation when compared to BMS.
I think what the NHC doctor said was correct. Artery below 2mm is not quite suitable for stenting and only do it when really bo pian and very badly clogged. The general guideline is above 60% then can consider stenting. If blockage is 70% and above, stenting is advisable. For below 2mm artery, BMS or high late-loss DES like Endeavor is not suitable.
At the said time of operation (Dec 2004), only Taxus and Cypher is available. So this case probably has nothing to do with Biomatrix unless she happen to be involved in BIG first clinical trial STEALTH1 single arm clinical trial. The doctors at NUH is also not wrong to recommend her to use DES since for 2mm artery, late-loss is a major concern. BMS has very high late-loss and may re-block the artery if the healing process is overly aggressive and bad scarring. Taxus (BSX) late-loss is higher than Cypher (JNJ). If the doctor at NUH is good, should NOT allow the patient to use Taxus. I suspect the patient may be implanted with Taxus but this is just my guess. Cypher was approved more than one year before Taxus. Sometimes even after approval, the DES manufacturer may want to continue further clinical trials (eg: Suitability of this brand of DES on women only - yes there are such clinical trials going on ; Suitability of DES on Asian patients with thinner vessel wall - Ang Mohs are found to have thicker vessel wall, maybe because they eat more beef?) The artery kena re-clogged and needed a second implant at the same location which is no good for the patient. I not sure if it will affect the patient's quality of life after the second implant but you can imagine 2 stents (wire mesh) interlapping on the same location on a < 2mm artery with a very thin vessel wall. Quite dangerous.
The suit will definitely need to call on expert opinion and witness. I hope the doctor has at least 2 good independent witness (hospital nurse/attendent/etc). I don't think the doctor will be so bird as to ask the patient to sign on the dotted line only after he sedated her and then make the patient agree to go on a DES trial when the patient is not in lucid mind. The patient probably must have signed the consent letter ealier. Anyway, how to make the patient sign after being sedated and lying on the bed? I think the doctor's words probably more credible than what the patient alleged. I think there could be a miscommunication when the doctor recommended the patient to go on a DES trial. DES and BMS....... maybe the patient also blur and duno what's the real difference and what she is really getting into. So now the DES screwed-up, she twist the sequence of events and sue the doctor lor.
Heard from a very reliable source that the stent used is from JNJ.
The story is not exactly about the failed DES and the patient is still alive! She is suing the NUH and TTSH for negligence. In Feb 2003 she underwent a coronary angiogram at the NHC which showed that her arteries were 60% blocked. She was advised against getting a heart stent by the NHC as her blocked artery was under 2mm in diameter which made her an unsuitable candidate. 22 months later she consulted TTSH for heart pains and was referred to NUH for stent implantation as new tests showed that the artery at 70% blockage was suitable for a stent implantation. Her contention is that the consultant cardiologist at NUH got her to consent to take part in a trial for a DES after she had been sedated when she had earlier given her consent for a bare stent. The cardiologist's version is that she had agreed to be given a DES before she was taken to the operating table and sedated. The stenting procedure in Dec 2004 was a success but after 8 months the artery with the DES had become 90% blocked so a second DES was implanted.
alamak, why close like that...also good lah, shake off the weaks hands now, so that the move upward will be smoother...
Har??? Got this type of tai chi happen again? Hope is not Biomatrix man........ This type of DES angioplasty depends a bit on luck also. Sometimes the patient more "sickly" than others, sometimes the doctor do the ops a bit cock-up (didn't place the stent properly or didn't inflate the balloon properly) and suay suay patient die and media print big big. Have to see whether is it due to the stent problem or other factors. The best is cut out the artery (including the DES inside) and send for post-mortem analysis. But the public generally still look at DES as a whole group and will affect the image of Biomatrix even if it is other brands that caused patient death. Does anyone has the S.Times multi-media of the article Bernie is talking about? Can post it here please? Its very unfair to lump the all DES under one group. How can Taxus compare with Biomatrix? This market leader already kena beaten so badly by Biomatrix in clinical trials. Media still always lump them together as DES and having the same performance standards and dangers. Grossly unfair!
